CNS Pharmaceuticals, Inc. (CNSP)
USD 0.11
(0.0%)
USD 0.11
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 4134.00 | 11.75 Thousand | 13.07 Thousand | 11.09 Thousand | 1955.00 | - |
| Gross Profit | -4134.00 | -11.75 Thousand | -13.07 Thousand | -11.09 Thousand | -1955.00 | - |
| Operating Expenses | 18.86 Million | 15.26 Million | 14.02 Million | 9.45 Million | 3.83 Million | 881.78 Thousand |
| Selling, General and Administrative Expenses | 4.76 Million | 5.96 Million | 4.68 Million | 4.39 Million | 1.97 Million | 860.52 Thousand |
| Research and Development Expenses | 14.09 Million | 9.3 Million | 9.34 Million | 5.06 Million | 1.85 Million | 21.26 Thousand |
| Other Expenses | - | - | - | - | - | -6.46 Million |
| Cost and Expenses | 18.86 Million | 15.26 Million | 14.02 Million | 9.45 Million | 3.83 Million | 881.78 Thousand |
| Operating Income | -18.86 Million | -15.26 Million | -14.02 Million | -9.45 Million | -3.83 Million | -881.78 Thousand |
| Interest Expense | - | 7027.00 | 9285.00 | 3264.00 | 44.23 Thousand | 46.69 Thousand |
| Income Tax Expense | - | 7027.00 | 9285.00 | 3264.00 | 42.27 Thousand | 46.69 Thousand |
| Earnings before Tax | -18.85 Million | -15.27 Million | -14.03 Million | -9.45 Million | -3.87 Million | -7.39 Million |
| Net Income | -18.85 Million | -15.27 Million | -14.49 Million | -9.45 Million | -3.87 Million | -7.39 Million |
| Earnings Per Share Basic | -251.35 | -560.83 | -852.66 | -859.81 | -353.57 | -674.07 |
| Earnings Per Share Diluted | -250.19 | -560.83 | -825.04 | -853.68 | -353.57 | -674.07 |
| Weighted Average Shares Outstanding | 75 Thousand | 27.23 Million | 17 Million | 11 Million | 10.96 Million | 10.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.34 Thousand | 27.23 Million | 17.56 Million | 11.07 Million | 10.96 Million | 10.96 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -18.86 Million | -15.25 Million | -14.47 Million | -9.44 Million | -3.83 Million | -6.46 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 6362.00 | - | - |
| Cost of Revenue | 752.00 | 818.00 | 4134.00 | 953.00 | 899.00 | 1003.00 |
| Gross Profit | -752.00 | -818.00 | -4134.00 | 5409.00 | -899.00 | -1003.00 |
| Operating Expenses | 2.52 Million | 3.54 Million | 18.86 Million | 5.37 Million | 4.53 Million | 4.02 Million |
| Selling, General and Administrative Expenses | 1.41 Million | 1.11 Million | - | 1.1 Million | 1.12 Million | 1.17 Million |
| Research and Development Expenses | 1.11 Million | 2.43 Million | - | 4.27 Million | 3.41 Million | 2.84 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2.52 Million | 3.54 Million | 18.86 Million | 5.37 Million | 4.53 Million | 4.02 Million |
| Operating Income | -2.52 Million | -3.54 Million | -18.86 Million | -5.37 Million | -4.53 Million | -4.02 Million |
| Interest Expense | 4463.00 | 6625.00 | -13.8 Thousand | 2881.00 | 1838.00 | 3650.00 |
| Income Tax Expense | -2.00 | 2.00 | -4.00 | -3.00 | 12.88 Thousand | 7802.00 |
| Earnings before Tax | -2.53 Million | -3.54 Million | -18.85 Million | -5.37 Million | -4.52 Million | -4.02 Million |
| Net Income | -2.53 Million | -3.54 Million | -18.85 Million | -5.37 Million | -4.52 Million | -4.02 Million |
| Earnings Per Share Basic | -6.72 | -20.61 | - | -53.22 | -54.14 | -51.86 |
| Earnings Per Share Diluted | -6.72 | -20.34 | - | -52.84 | -54.14 | -51.86 |
| Weighted Average Shares Outstanding | 376.64 Thousand | 172 Thousand | 75.34 Thousand | 101 Thousand | 83.54 Thousand | 77.54 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 376.64 Thousand | 174.25 Thousand | 75.34 Thousand | 101.72 Thousand | 83.54 Thousand | 77.54 Thousand |
| Gross Margin | - | - | - | 0.85 | - | - |
| EBIT Margin | - | - | - | -845.40 | - | - |
| Profit Margin | - | - | - | -844.90 | - | - |
| EBITDA | -2.52 Million | -3.54 Million | - | -5.37 Million | -4.52 Million | -4.01 Million |
| Earnings Before Tax Margin | - | - | - | -845.55 | - | - |
SKY
IFA
BETSF
2886
4197
601318